Intradermal naked plasmid DNA immunization: mechanisms of action
- PMID: 21854310
- DOI: 10.1586/erv.11.66
Intradermal naked plasmid DNA immunization: mechanisms of action
Abstract
Plasmid DNA is a promising vaccine modality that is regularly examined in prime-boost immunization regimens. Recent advances in skin immunity increased our understanding of the sophisticated cutaneous immune network, which revived scientific interest in delivering vaccines to the skin. Intradermal administration of plasmid DNA via needle injection is a simple and inexpensive procedure that exposes the plasmid and its encoded antigen to the dermal immune surveillance system. This triggers unique mechanisms for eliciting local and systemic immunity that can confer protection against pathogens and tumors. Understanding the mechanisms of intradermal plasmid DNA immunization is essential for enhancing and modulating its immunogenicity. With regard to vaccination, this is of greater importance as this routine injection technique is highly desirable for worldwide immunization. This article will focus on the current understanding of the mechanisms involved in antigen expression and presentation during primary and secondary syringe and needle intradermal plasmid DNA immunization.
Similar articles
-
Injection site-dependent induction of immune response by DNA vaccine: comparison of skin and spleen as a target for vaccination.J Gene Med. 2010 Mar;12(3):301-9. doi: 10.1002/jgm.1432. J Gene Med. 2010. PMID: 20084616
-
Modulating specific priming of immune effector functions by DNA-based vaccination strategies.Dev Biol (Basel). 2000;104:15-24. Dev Biol (Basel). 2000. PMID: 11713813
-
Chemical adjuvants for plasmid DNA vaccines.Vaccine. 2007 May 10;25(19):3731-41. doi: 10.1016/j.vaccine.2007.01.120. Epub 2007 Feb 20. Vaccine. 2007. PMID: 17350735 Review.
-
Directly transfected langerin+ dermal dendritic cells potentiate CD8+ T cell responses following intradermal plasmid DNA immunization.J Immunol. 2010 Sep 15;185(6):3463-71. doi: 10.4049/jimmunol.1001825. Epub 2010 Aug 16. J Immunol. 2010. PMID: 20713888
-
Optimization and delivery of plasmid DNA for vaccination.Expert Rev Vaccines. 2006 Dec;5(6):803-25. doi: 10.1586/14760584.5.6.803. Expert Rev Vaccines. 2006. PMID: 17184219 Review.
Cited by
-
Intradermal delivery of a fractional dose of influenza H7N9 split vaccine elicits protective immunity in mice and rats.Hum Vaccin Immunother. 2018 Mar 4;14(3):623-629. doi: 10.1080/21645515.2017.1423156. Epub 2018 Feb 12. Hum Vaccin Immunother. 2018. PMID: 29400997 Free PMC article.
-
Toll-Like Receptor 9 Activation Rescues Impaired Antibody Response in Needle-free Intradermal DNA Vaccination.Sci Rep. 2016 Sep 23;6:33564. doi: 10.1038/srep33564. Sci Rep. 2016. PMID: 27658623 Free PMC article.
-
Immunogenic Comparison of Nucleic Acid-Based Vaccines Administered by Pyro-Drive Jet Injector.Vaccines (Basel). 2024 Jul 9;12(7):757. doi: 10.3390/vaccines12070757. Vaccines (Basel). 2024. PMID: 39066395 Free PMC article.
-
Codon optimization and improved delivery/immunization regimen enhance the immune response against wild-type and drug-resistant HIV-1 reverse transcriptase, preserving its Th2-polarity.Sci Rep. 2018 May 24;8(1):8078. doi: 10.1038/s41598-018-26281-z. Sci Rep. 2018. PMID: 29799015 Free PMC article.
-
Increasing the Vaccine Potential of Live M. bovis BCG by Coadministration with Plasmid DNA Encoding a Tuberculosis Prototype Antigen.Vaccines (Basel). 2014 Mar 5;2(1):181-95. doi: 10.3390/vaccines2010181. Vaccines (Basel). 2014. PMID: 26344474 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources